News
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
Health on MSN7d
Ozempic Users May Face Higher Risk of a Serious Eye DiseaseA new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback